Progress in transformation therapy for pancreatic neuroendocrine neoplasms
10.3877/cma.j.issn.2095-3232.2024.04.003
- Author:
Xiaowei Deng
- Publication Type:Editorial
- From:
Chinese Journal of Hepatic Surgery（Electronic Edition）
2024;13(4):456-
- CountryChina
- Language:Chinese
-
Abstract:
Neuroendocrine neoplasms (NENs) are heterogeneous neoplasms. NENs arising from the stomach, bowel and pancreas can be divided into high-differentiated neuroendocrine tumors (NET) and neuroendocrine carcinoma, among which high-differentiated NET can be subdivided into NET G1, G2 and NET G3 according to Ki-67 index, and classified into functional NET and non-functional NET according to the function of hormone secretion. NF-NET is the dominant type, manifested with elusive onset. Many patients have local progression and/or distant metastasis upon diagnosis. Transformation therapy is of significance for patients with advanced NET. In this article, common transformation therapies were summarized based on different biological behaviors of advanced tumors. According to the characteristics of different types of tumors, appropriate treatment approaches were determined. Drug combination therapy should be carried out to achieve precise and individualized treatment when necessary.
- Full text:2024121110554613883456.pdf
